HUT49149A - Process for production of derivatives of amin acid and medical compositions containing them as active substance - Google Patents
Process for production of derivatives of amin acid and medical compositions containing them as active substanceInfo
- Publication number
- HUT49149A HUT49149A HU881623A HU162388A HUT49149A HU T49149 A HUT49149 A HU T49149A HU 881623 A HU881623 A HU 881623A HU 162388 A HU162388 A HU 162388A HU T49149 A HUT49149 A HU T49149A
- Authority
- HU
- Hungary
- Prior art keywords
- derivatives
- production
- active substance
- compositions containing
- medical compositions
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 239000013543 active substance Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19873711335 DE3711335A1 (de) | 1987-04-03 | 1987-04-03 | Aminosaeurederivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUT49149A true HUT49149A (en) | 1989-08-28 |
Family
ID=6324839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU881623A HUT49149A (en) | 1987-04-03 | 1988-04-01 | Process for production of derivatives of amin acid and medical compositions containing them as active substance |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0284942A3 (hu) |
| JP (1) | JPS63258894A (hu) |
| KR (1) | KR880012641A (hu) |
| AU (1) | AU1413488A (hu) |
| DE (1) | DE3711335A1 (hu) |
| HU (1) | HUT49149A (hu) |
| ZA (1) | ZA882347B (hu) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2217319A (en) * | 1988-04-19 | 1989-10-25 | Synpharm Ltd | Racemic and optically active fatty amino acids, their homo- abd hetero-oligomers and conjugates, the process of their production, their pharmaceutical composi |
| AU638264B2 (en) * | 1989-08-10 | 1993-06-24 | Aventis Inc. | Cyclic neurokinin a antagonists |
| EP0515681A4 (en) * | 1990-02-15 | 1993-12-29 | Fujisawa Pharmaceutical Co., Ltd. | Peptide compound |
| DE4007869A1 (de) * | 1990-03-13 | 1991-09-19 | Merck Patent Gmbh | Aminosaeurederivate |
| AU646966B2 (en) * | 1991-08-23 | 1994-03-10 | Takeda Chemical Industries Ltd. | 2-piperazinone compounds, their production and use |
| EP0919245A3 (en) | 1991-09-20 | 2000-11-15 | Glaxo Group Limited | NK-1 receptor antagonist and a systemic antiinflammatory corticosteroid for the treatment of emesis |
| GR1001405B (el) * | 1992-05-15 | 1993-11-30 | Takeda Chemical Industries Ltd | Ενώσεις 2-πιπεραζινόνης και η παραγωγή και η χρησιμοποίηση αυτών. |
| DE4302485A1 (de) * | 1993-01-29 | 1994-08-04 | Merck Patent Gmbh | Piperazinderivate |
| GB9702377D0 (en) * | 1996-02-23 | 1997-03-26 | Zeneca Ltd | Peptide derivatives |
| ATE283278T1 (de) | 1996-06-07 | 2004-12-15 | Astrazeneca Ab | Peptid derivate |
| GB9621836D0 (en) | 1996-10-19 | 1996-12-11 | Zeneca Ltd | Peptide compounds |
| GB9624562D0 (en) | 1996-11-27 | 1997-01-15 | Zeneca Ltd | Peptide derivatives |
| AU7127298A (en) * | 1997-04-14 | 1998-11-11 | Emory University | Serine protease inhibitors |
| MY130373A (en) * | 2001-10-29 | 2007-06-29 | Malesci Sas | Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| CN101641099A (zh) | 2007-01-24 | 2010-02-03 | 葛兰素集团有限公司 | 包含3,5-二氨基-6-(2,3-二氯苯基)-1,2,4-三嗪或r(-)-2,4-二氨基-5-(2,3-二氯苯基)-6-氟甲基嘧啶和nk1的药物组合物 |
| UA105182C2 (ru) | 2008-07-03 | 2014-04-25 | Ньюрексон, Інк. | Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность |
| US9446029B2 (en) | 2010-07-27 | 2016-09-20 | Colorado State University Research Foundation | Use of NK-1 receptor antagonists in management of visceral pain |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3378121D1 (de) * | 1982-10-18 | 1988-11-03 | Ici Plc | Peptide and pseudopeptide derivatives |
| EP0176436A3 (en) * | 1984-09-26 | 1987-12-16 | Merck & Co. Inc. | Analogs of substance p and eledoisin |
-
1987
- 1987-04-03 DE DE19873711335 patent/DE3711335A1/de not_active Withdrawn
-
1988
- 1988-03-21 EP EP19880104483 patent/EP0284942A3/de not_active Withdrawn
- 1988-03-30 KR KR1019880003530A patent/KR880012641A/ko not_active Withdrawn
- 1988-03-31 ZA ZA882347A patent/ZA882347B/xx unknown
- 1988-03-31 AU AU14134/88A patent/AU1413488A/en not_active Abandoned
- 1988-04-01 JP JP63078334A patent/JPS63258894A/ja active Pending
- 1988-04-01 HU HU881623A patent/HUT49149A/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0284942A3 (de) | 1990-09-05 |
| DE3711335A1 (de) | 1988-10-20 |
| JPS63258894A (ja) | 1988-10-26 |
| KR880012641A (ko) | 1988-11-28 |
| ZA882347B (en) | 1988-09-23 |
| AU1413488A (en) | 1988-10-06 |
| EP0284942A2 (de) | 1988-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT47596A (en) | Process for production of derivatives of amin acid and medical compositions containing them as active substance | |
| HUT50152A (en) | Process for production of derivatives of benzopiran and medical compositions containing them as active substance | |
| HUT49147A (en) | Process for production of derivatives of amin acid and medical compositions containg them as active substance | |
| HUT47576A (en) | Process for production of 2-amin-purin-derivatives and medical compositions containing them as active substance | |
| HUT42479A (en) | Process for production of derivatives of quinasoline and medical preparatives containing thereof as active substance | |
| HUT44489A (en) | Process for production of derivatives of benzosulphonamid-indanyl and medical preparatives containing them as active substance | |
| HUT47568A (en) | Process for production of derivatives of tiazepine and medical compositions containing them | |
| HUT43837A (en) | Process for production of n-benzhydril-diazacycloalkylalcane-anilides and medical compounds containing thereof as active substance | |
| HUT49149A (en) | Process for production of derivatives of amin acid and medical compositions containing them as active substance | |
| HUT47592A (en) | Process for production of derivatives of dideoxicitidin and medical compositions containg them as active substance | |
| HUT48581A (en) | Process for production of derivatives of substituated pirrol and medical preparatives containing them as active substance | |
| HUT46900A (en) | Process for production of derivatives of 7-/acyl-oxi/-6-/amin-axyl-oxi/-polioxi-labdane and medical compounds containing them as active substance | |
| HUT45968A (en) | Process for production of derivatives of substituated amin and medical compositions containing these compounds | |
| HUT50194A (en) | Process for production of new derivatives of neplanocine and medical compositions containing them as active substance | |
| HUT47909A (en) | Process for production of substituated alcane-carbonic acid amids and their derivatives and medical compositions containing them | |
| HUT40098A (en) | Process for production of halogen-hidroxi-flavons and medical preparatives containing thereof as active substance | |
| HUT47594A (en) | Process for production of new derivatives of furanuronic acid and medical compositions containing them | |
| HUT51284A (en) | Process for production of epipodofillotoxin glucozides substituated by fluor and medical compositions containing them as active substance | |
| HUT50485A (en) | Process for production of derivatives of amin acid and medical compositions containing them as active substance | |
| HUT47600A (en) | Process for production of encephalinase glykopeptids, amin acid derivatives with hindering effect and medical compositions containing them | |
| HUT43580A (en) | Process for production of derivatives of carbonic acid and medical compounds containing thereof as active substance | |
| HUT43592A (en) | Process for production of derivatives of nitrofurane and medical compounds containing thereof as active substance | |
| HUT45268A (en) | Process for production of tripeptide-agregations and medical preparatives containing them as active substance | |
| HUT49148A (en) | Process for production of derivatives of amin acid and medical compositions containing them as active substance | |
| HUT50762A (en) | Process for production of medical compositions containing as active substance derivatives of pirrol and process for production of the active substance |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DFD9 | Temporary prot. cancelled due to non-payment of fee |